GH Research PLC (GHRS) vs Immunocore Holdings PLC Sponsored ADR (IMCR)
GH Research PLC and Immunocore Holdings PLC Sponsored ADR are both Biotechnology companies. GH Research PLC and Immunocore Holdings PLC Sponsored ADR are of similar size ($1.7B and $1.6B). GH Research PLC has the higher net margin (0.00% vs −4.20%) and the higher return on invested capital (0.00% vs 0.00%). Across the 13 metrics below, Immunocore Holdings PLC Sponsored ADR leads on 7 and GH Research PLC on 6.
Valuation
Profitability
| Metric | GHRS | IMCR | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 98.90% | 65.16% |
| Operating margin | 0.00% | (5.24%) | 0.00% |
| Net margin | 0.00% | (4.20%) | 0.00% |
| Free cash flow margin | 0.00% | (9.55%) | 0.00% |
| Return on equity | (18.79%) | (4.47%) | (57.72%) |
| Return on assets | (18.16%) | (1.64%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack